Dataset Information


Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.

ABSTRACT: A safe and effective adjuvant is necessary to induce reliable protective efficacy of the protein-based vaccines against tuberculosis (TB). Mycobacterial components, such as synthetic cord factor and arabinogalactan, have been used as one of the adjuvant components. Mycobacterium bovis bacillus Calmette- Guérin cell-wall skeleton (BCG-CWS) has been used as an effective immune-stimulator. However, it is not proven whether BCG-CWS can be an effective adjuvant for the subunit protein vaccine of TB. In this study, we demonstrated that the BCG-CWS effectively coupled with Ag85B and enhanced the conjugated Ag85B activity on the maturation of dendritic cells (DCs). Ag85B-BCG-CWS-matured DCs induced significant Th1 and Th17 responses when compared to BCG-CWS or Ag85B alone. In addition, significant Ag85B-specific Th1 and Th17 responses were induced in Ag85B-BCG-CWS-immunized mice before infection with M. tuberculosis and maintained after infection. Moreover, Ag85B-BCG-CWS showed significant protective effect comparable to live BCG at 6 weeks after infection and maintained its protective efficacy at 32 weeks post-challenge, whereas live BCG did not. These results suggest that the BCG-CWS may be an effective adjuvant candidate for a protein-based vaccine against TB.


PROVIDER: S-EPMC6407753 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4635936 | BioStudies
2019-01-01 | S-EPMC6598733 | BioStudies
2019-01-01 | S-EPMC6803339 | BioStudies
2011-01-01 | S-EPMC3213116 | BioStudies
2015-01-01 | S-EPMC4378938 | BioStudies
2018-01-01 | S-EPMC6204737 | BioStudies
2018-01-01 | S-EPMC5875036 | BioStudies
2013-01-01 | S-EPMC3871206 | BioStudies
2012-01-01 | S-EPMC3386939 | BioStudies
2020-01-01 | S-EPMC7269335 | BioStudies